Acne News

  • Dermira to Abandon Acne Drug, Shares Crater Dermira Inc will discontinue development of its acne drug after the treatment failed to meet the main goals of two late-stage studies, the company said on Monday.
  • Depression Risk Rises With New Acne Diagnosis In the first year after a new diagnosis of acne, patients’ risk for a diagnosis of major depressive disorder spikes by more than 60 percent compared to the general population, a new study shows.

Acne Perspective


Acne Journal Articles